

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular epithelial cell development (GO:0072310) | 9.77363473 |
| 2 | glomerular basement membrane development (GO:0032836) | 8.51618294 |
| 3 | surfactant homeostasis (GO:0043129) | 7.21208951 |
| 4 | skeletal muscle contraction (GO:0003009) | 7.00821483 |
| 5 | NADH metabolic process (GO:0006734) | 6.26403683 |
| 6 | chemical homeostasis within a tissue (GO:0048875) | 5.84573569 |
| 7 | creatine metabolic process (GO:0006600) | 5.72386640 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.62917036 |
| 9 | glomerulus development (GO:0032835) | 5.54104279 |
| 10 | regulation of cell communication by electrical coupling (GO:0010649) | 5.32768366 |
| 11 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.19337293 |
| 12 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.05578783 |
| 13 | response to inactivity (GO:0014854) | 5.04334910 |
| 14 | striated muscle hypertrophy (GO:0014897) | 4.87768436 |
| 15 | response to muscle activity (GO:0014850) | 4.71491530 |
| 16 | muscle contraction (GO:0006936) | 4.67109324 |
| 17 | sarcomere organization (GO:0045214) | 4.51630442 |
| 18 | positive regulation of p38MAPK cascade (GO:1900745) | 4.49066068 |
| 19 | lymphangiogenesis (GO:0001946) | 4.47068282 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.41907835 |
| 21 | muscle hypertrophy (GO:0014896) | 4.38934720 |
| 22 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.38595364 |
| 23 | regulation of the force of heart contraction (GO:0002026) | 4.22429549 |
| 24 | muscle system process (GO:0003012) | 4.21978318 |
| 25 | regulation of striated muscle contraction (GO:0006942) | 4.20204755 |
| 26 | regulation of p38MAPK cascade (GO:1900744) | 4.13191254 |
| 27 | striated muscle adaptation (GO:0014888) | 4.10451186 |
| 28 | skeletal muscle fiber development (GO:0048741) | 4.05532895 |
| 29 | venous blood vessel morphogenesis (GO:0048845) | 4.01936821 |
| 30 | adult heart development (GO:0007512) | 4.00053113 |
| 31 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.99074542 |
| 32 | cardiac myofibril assembly (GO:0055003) | 3.97801572 |
| 33 | coronary vasculature morphogenesis (GO:0060977) | 3.95619341 |
| 34 | glucan catabolic process (GO:0009251) | 3.91577001 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.91301421 |
| 36 | glycogen catabolic process (GO:0005980) | 3.86736707 |
| 37 | angiotensin maturation (GO:0002003) | 3.84704726 |
| 38 | endothelial cell chemotaxis (GO:0035767) | 3.83417750 |
| 39 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.82349573 |
| 40 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.78302323 |
| 41 | muscle filament sliding (GO:0030049) | 3.72162919 |
| 42 | actin-myosin filament sliding (GO:0033275) | 3.72162919 |
| 43 | muscle fiber development (GO:0048747) | 3.71834266 |
| 44 | myofibril assembly (GO:0030239) | 3.71818185 |
| 45 | myotube cell development (GO:0014904) | 3.71814567 |
| 46 | heart contraction (GO:0060047) | 3.69896437 |
| 47 | heart process (GO:0003015) | 3.69896437 |
| 48 | renal filtration (GO:0097205) | 3.69472246 |
| 49 | lymph vessel development (GO:0001945) | 3.68724227 |
| 50 | cellular polysaccharide catabolic process (GO:0044247) | 3.67968591 |
| 51 | fructose metabolic process (GO:0006000) | 3.66356757 |
| 52 | plasma membrane repair (GO:0001778) | 3.64882376 |
| 53 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.62180533 |
| 54 | cardiac muscle adaptation (GO:0014887) | 3.58441272 |
| 55 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.58441272 |
| 56 | muscle hypertrophy in response to stress (GO:0003299) | 3.58441272 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.58165238 |
| 58 | skeletal muscle tissue development (GO:0007519) | 3.49711123 |
| 59 | regulation of skeletal muscle contraction (GO:0014819) | 3.47942079 |
| 60 | actin-mediated cell contraction (GO:0070252) | 3.47107561 |
| 61 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.45311263 |
| 62 | protein localization to endosome (GO:0036010) | 3.44267968 |
| 63 | regulation of vasculogenesis (GO:2001212) | 3.43900258 |
| 64 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.42754544 |
| 65 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.42754544 |
| 66 | actomyosin structure organization (GO:0031032) | 3.39074031 |
| 67 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.37892592 |
| 68 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.34206744 |
| 69 | polysaccharide catabolic process (GO:0000272) | 3.33314822 |
| 70 | regulation of glomerular filtration (GO:0003093) | 3.31460915 |
| 71 | muscle adaptation (GO:0043500) | 3.31147366 |
| 72 | carnitine shuttle (GO:0006853) | 3.30029282 |
| 73 | glucan biosynthetic process (GO:0009250) | 3.29873633 |
| 74 | glycogen biosynthetic process (GO:0005978) | 3.29873633 |
| 75 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.29848364 |
| 76 | lung vasculature development (GO:0060426) | 3.27575218 |
| 77 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.27281087 |
| 78 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.27201178 |
| 79 | fatty acid transmembrane transport (GO:1902001) | 3.26736369 |
| 80 | blood vessel maturation (GO:0001955) | 3.24838156 |
| 81 | striated muscle cell development (GO:0055002) | 3.24458901 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.24406708 |
| 83 | muscle atrophy (GO:0014889) | 3.24207622 |
| 84 | relaxation of muscle (GO:0090075) | 3.23585659 |
| 85 | regulation of membrane repolarization (GO:0060306) | 3.23327831 |
| 86 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.23119429 |
| 87 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.19608462 |
| 88 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.19608462 |
| 89 | regulation of axon guidance (GO:1902667) | 3.18465002 |
| 90 | regulation of sequestering of triglyceride (GO:0010889) | 3.17367390 |
| 91 | cardiac muscle cell development (GO:0055013) | 3.16467163 |
| 92 | cell adhesion mediated by integrin (GO:0033627) | 3.15851539 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15802593 |
| 94 | tricarboxylic acid cycle (GO:0006099) | 3.15507064 |
| 95 | positive regulation of vascular permeability (GO:0043117) | 3.12809533 |
| 96 | actin filament-based movement (GO:0030048) | 3.12655367 |
| 97 | response to epinephrine (GO:0071871) | 3.12112061 |
| 98 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11697293 |
| 99 | regulation of heart rate (GO:0002027) | 3.11595220 |
| 100 | regulation of actin filament-based movement (GO:1903115) | 3.09677339 |
| 101 | epithelial cell-cell adhesion (GO:0090136) | 3.09643832 |
| 102 | skeletal muscle adaptation (GO:0043501) | 3.09345039 |
| 103 | regulation of cardioblast differentiation (GO:0051890) | 3.05638830 |
| 104 | regulation of vascular permeability (GO:0043114) | 3.05173639 |
| 105 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.04138770 |
| 106 | endothelium development (GO:0003158) | 3.03949261 |
| 107 | patterning of blood vessels (GO:0001569) | 3.03576726 |
| 108 | regulation of ATP catabolic process (GO:1903289) | 3.02519164 |
| 109 | regulation of ATPase activity (GO:0043462) | 3.02519164 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.01935416 |
| 111 | regulation of muscle system process (GO:0090257) | 3.00499233 |
| 112 | heart trabecula formation (GO:0060347) | 3.00339237 |
| 113 | morphogenesis of an endothelium (GO:0003159) | 2.99547070 |
| 114 | endothelial tube morphogenesis (GO:0061154) | 2.99547070 |
| 115 | regulation of muscle contraction (GO:0006937) | 2.98989645 |
| 116 | positive regulation of cation channel activity (GO:2001259) | 2.98903769 |
| 117 | cardiac cell development (GO:0055006) | 2.98245761 |
| 118 | cardiac muscle contraction (GO:0060048) | 2.97013341 |
| 119 | cardiac muscle cell action potential (GO:0086001) | 2.96970794 |
| 120 | muscle cell cellular homeostasis (GO:0046716) | 2.96893975 |
| 121 | regulation of relaxation of muscle (GO:1901077) | 2.96637282 |
| 122 | positive regulation of vasculogenesis (GO:2001214) | 2.96201051 |
| 123 | cellular response to epinephrine stimulus (GO:0071872) | 2.95700438 |
| 124 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.93032037 |
| 125 | striated muscle atrophy (GO:0014891) | 2.89890968 |
| 126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.86703639 |
| 127 | glomerular filtration (GO:0003094) | 2.86097763 |
| 128 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.85552704 |
| 129 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.85054492 |
| 130 | blood vessel endothelial cell migration (GO:0043534) | 2.84332587 |
| 131 | renal system process involved in regulation of blood volume (GO:0001977) | 2.82631768 |
| 132 | hemidesmosome assembly (GO:0031581) | 2.81499432 |
| 133 | relaxation of cardiac muscle (GO:0055119) | 2.76730189 |
| 134 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.75799355 |
| 135 | cell communication involved in cardiac conduction (GO:0086065) | 2.74421671 |
| 136 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.72693271 |
| 137 | negative regulation of axon guidance (GO:1902668) | 2.65517910 |
| 138 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.61870096 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61126220 |
| 140 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.61054351 |
| 141 | blood vessel remodeling (GO:0001974) | 2.59823044 |
| 142 | stress fiber assembly (GO:0043149) | 2.59768223 |
| 143 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.58838648 |
| 144 | muscle tissue morphogenesis (GO:0060415) | 2.58266569 |
| 145 | mesodermal cell differentiation (GO:0048333) | 2.58242984 |
| 146 | sprouting angiogenesis (GO:0002040) | 2.58146092 |
| 147 | striated muscle contraction (GO:0006941) | 2.57536675 |
| 148 | carnitine transmembrane transport (GO:1902603) | 2.57432903 |
| 149 | cardiac muscle hypertrophy (GO:0003300) | 2.57349743 |
| 150 | artery development (GO:0060840) | 2.56314742 |
| 151 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.55444749 |
| 152 | desmosome organization (GO:0002934) | 2.52856682 |
| 153 | positive regulation of focal adhesion assembly (GO:0051894) | 2.52467676 |
| 154 | positive regulation of cell junction assembly (GO:1901890) | 2.52467676 |
| 155 | carnitine transport (GO:0015879) | 2.52255532 |
| 156 | amino-acid betaine transport (GO:0015838) | 2.52255532 |
| 157 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.51118172 |
| 158 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.50540522 |
| 159 | glomerular visceral epithelial cell development (GO:0072015) | 10.8474745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92149686 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63659955 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.39918799 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79564000 |
| 5 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.79335891 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.77088222 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.70632981 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.67986908 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57137415 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.56638444 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.48722482 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.48309808 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.41805876 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.39562748 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31400887 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23826195 |
| 17 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.15739018 |
| 18 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.15739018 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.06908138 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.90173485 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.89266778 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85755259 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.84065915 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.82812385 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73467716 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70913933 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68644057 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68135579 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61961404 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60174141 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57820936 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53134005 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52903668 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52851834 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51010607 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50523921 |
| 37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48471407 |
| 38 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.45699201 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45061428 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.43919624 |
| 41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43882013 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39982859 |
| 43 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.39595394 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.37294562 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36723084 |
| 46 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.36574067 |
| 47 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36301622 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35066543 |
| 49 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33522053 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31562478 |
| 51 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31367436 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31110520 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30488743 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27937326 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26968460 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25404511 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23068256 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22980598 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20562624 |
| 60 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19866522 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17398531 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16549663 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15268176 |
| 64 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.15140751 |
| 65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14213967 |
| 66 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13841656 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11178142 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10655463 |
| 69 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09405305 |
| 70 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09360974 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09132538 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08771334 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07973585 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07956814 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07956814 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07821239 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07549726 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07065617 |
| 79 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05776177 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05675066 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04906773 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03367027 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03003046 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02282184 |
| 85 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01186468 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00506489 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00456353 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99594792 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97701474 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96916232 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96916232 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95657680 |
| 93 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95608841 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95084966 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94667542 |
| 96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94445195 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94356587 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94266438 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92914229 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91740476 |
| 101 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90126360 |
| 102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89456260 |
| 103 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89456260 |
| 104 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88751523 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88045043 |
| 106 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87686334 |
| 107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87275616 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87185910 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86949676 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85858839 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85799141 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85687430 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85047176 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84484778 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83342275 |
| 116 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83299875 |
| 117 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83030298 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82427921 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81056243 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78548727 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76360721 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75892061 |
| 123 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.74937063 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.72723256 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72414064 |
| 126 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.72206697 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70509930 |
| 128 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.68472293 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.68430743 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68157425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 4.89221168 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.18446764 |
| 3 | MP0004036_abnormal_muscle_relaxation | 3.60742457 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.51788534 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.44512449 |
| 6 | MP0004272_abnormal_basement_membrane | 3.07851283 |
| 7 | MP0000751_myopathy | 2.93044917 |
| 8 | MP0004215_abnormal_myocardial_fiber | 2.85753590 |
| 9 | MP0003646_muscle_fatigue | 2.84131367 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.73040025 |
| 11 | MP0005451_abnormal_body_composition | 2.64925958 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.45577341 |
| 13 | MP0005330_cardiomyopathy | 2.39983024 |
| 14 | MP0001958_emphysema | 2.39779186 |
| 15 | MP0000749_muscle_degeneration | 2.39141715 |
| 16 | MP0006138_congestive_heart_failure | 2.35757282 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.28843300 |
| 18 | MP0004130_abnormal_muscle_cell | 2.25986471 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 2.24566202 |
| 20 | MP0005385_cardiovascular_system_phenoty | 2.24566202 |
| 21 | MP0003828_pulmonary_edema | 2.19763834 |
| 22 | MP0004484_altered_response_of | 2.16588093 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 2.14685078 |
| 24 | MP0004087_abnormal_muscle_fiber | 2.11605935 |
| 25 | MP0005620_abnormal_muscle_contractility | 2.03168585 |
| 26 | MP0005623_abnormal_meninges_morphology | 2.01072719 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.92211333 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.79983184 |
| 29 | MP0000343_altered_response_to | 1.66745228 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.64078102 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.62310606 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.57511036 |
| 33 | MP0000230_abnormal_systemic_arterial | 1.55784163 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.53348212 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.52812309 |
| 36 | MP0000747_muscle_weakness | 1.52437145 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.49086149 |
| 38 | MP0002108_abnormal_muscle_morphology | 1.48804330 |
| 39 | MP0004085_abnormal_heartbeat | 1.43970895 |
| 40 | MP0005165_increased_susceptibility_to | 1.43918051 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.41600025 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.40409490 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.39145094 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.37989571 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.37824825 |
| 46 | MP0002269_muscular_atrophy | 1.37815692 |
| 47 | MP0004510_myositis | 1.26904348 |
| 48 | MP0003724_increased_susceptibility_to | 1.26890000 |
| 49 | MP0002971_abnormal_brown_adipose | 1.25565964 |
| 50 | MP0005369_muscle_phenotype | 1.25554230 |
| 51 | MP0002128_abnormal_blood_circulation | 1.24948739 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.23514996 |
| 53 | MP0005360_urolithiasis | 1.21968672 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.21864976 |
| 55 | MP0009384_cardiac_valve_regurgitation | 1.21460770 |
| 56 | MP0002136_abnormal_kidney_physiology | 1.21171178 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.20236899 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.16912130 |
| 59 | MP0005266_abnormal_metabolism | 1.16362774 |
| 60 | MP0005332_abnormal_amino_acid | 1.14029061 |
| 61 | MP0003279_aneurysm | 1.11992797 |
| 62 | MP0003091_abnormal_cell_migration | 1.11118226 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.10600822 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.10274277 |
| 65 | MP0003941_abnormal_skin_development | 1.07723536 |
| 66 | MP0001756_abnormal_urination | 1.05941444 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.05165076 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.04881367 |
| 69 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04694558 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.04647248 |
| 71 | MP0005388_respiratory_system_phenotype | 1.04374613 |
| 72 | MP0002133_abnormal_respiratory_system | 1.04374613 |
| 73 | MP0004043_abnormal_pH_regulation | 1.02281530 |
| 74 | MP0004233_abnormal_muscle_weight | 1.01037178 |
| 75 | MP0000266_abnormal_heart_morphology | 0.96649376 |
| 76 | MP0006054_spinal_hemorrhage | 0.93925915 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.93049703 |
| 78 | MP0001614_abnormal_blood_vessel | 0.92412011 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.91982776 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 0.91711690 |
| 81 | MP0004270_analgesia | 0.91235568 |
| 82 | MP0009840_abnormal_foam_cell | 0.91161248 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.89819293 |
| 84 | MP0005595_abnormal_vascular_smooth | 0.89213419 |
| 85 | MP0000249_abnormal_blood_vessel | 0.88554738 |
| 86 | MP0005670_abnormal_white_adipose | 0.86773386 |
| 87 | MP0002135_abnormal_kidney_morphology | 0.84643618 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83724223 |
| 89 | MP0001661_extended_life_span | 0.82143831 |
| 90 | MP0000534_abnormal_ureter_morphology | 0.81556816 |
| 91 | MP0008995_early_reproductive_senescence | 0.75843968 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.74771442 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71453580 |
| 94 | MP0001784_abnormal_fluid_regulation | 0.70356137 |
| 95 | MP0003045_fibrosis | 0.69918926 |
| 96 | MP0008004_abnormal_stomach_pH | 0.69915636 |
| 97 | MP0005275_abnormal_skin_tensile | 0.69637704 |
| 98 | MP0000516_abnormal_urinary_system | 0.69256301 |
| 99 | MP0005367_renal/urinary_system_phenotyp | 0.69256301 |
| 100 | MP0005409_darkened_coat_color | 0.68877010 |
| 101 | MP0003879_abnormal_hair_cell | 0.68788472 |
| 102 | MP0000733_abnormal_muscle_development | 0.67909524 |
| 103 | MP0004147_increased_porphyrin_level | 0.67452806 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.66072829 |
| 105 | MP0005085_abnormal_gallbladder_physiolo | 0.65176607 |
| 106 | MP0005187_abnormal_penis_morphology | 0.64405378 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.64228241 |
| 108 | MP0002822_catalepsy | 0.64105299 |
| 109 | MP0005166_decreased_susceptibility_to | 0.62227344 |
| 110 | MP0001666_abnormal_nutrient_absorption | 0.61763817 |
| 111 | MP0003252_abnormal_bile_duct | 0.61290990 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59957736 |
| 113 | MP0005535_abnormal_body_temperature | 0.59772060 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.55427159 |
| 115 | MP0009115_abnormal_fat_cell | 0.54696689 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.50340330 |
| 117 | MP0005334_abnormal_fat_pad | 0.50042034 |
| 118 | MP0001664_abnormal_digestion | 0.48158480 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.44165526 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.41542272 |
| 121 | MP0005365_abnormal_bile_salt | 0.40216250 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.35595332 |
| 123 | MP0003948_abnormal_gas_homeostasis | 0.34977793 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.34570081 |
| 125 | MP0002139_abnormal_hepatobiliary_system | 0.34504239 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.34148474 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.31641578 |
| 128 | MP0010329_abnormal_lipoprotein_level | 0.30866069 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.28707189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 6.21593890 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 5.22390969 |
| 3 | Sudden death (HP:0001699) | 5.15190357 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 4.88009160 |
| 5 | Myopathic facies (HP:0002058) | 4.81838691 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.68843601 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.66006822 |
| 8 | Polycythemia (HP:0001901) | 4.55853107 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.51664731 |
| 10 | Distal arthrogryposis (HP:0005684) | 4.46740110 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.29798510 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.25809937 |
| 13 | Glomerulosclerosis (HP:0000096) | 4.19497482 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.19230378 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 4.05991033 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 4.01706604 |
| 17 | Rimmed vacuoles (HP:0003805) | 3.97640101 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 3.89093398 |
| 19 | Hypoalbuminemia (HP:0003073) | 3.87244047 |
| 20 | Abnormal albumin level (HP:0012116) | 3.87244047 |
| 21 | Hematochezia (HP:0002573) | 3.87213880 |
| 22 | Round ear (HP:0100830) | 3.78956490 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.77247857 |
| 24 | Atrial fibrillation (HP:0005110) | 3.53946394 |
| 25 | Myoglobinuria (HP:0002913) | 3.52203792 |
| 26 | Nephritis (HP:0000123) | 3.50447486 |
| 27 | Ulnar deviation of the wrist (HP:0003049) | 3.48463998 |
| 28 | Increased connective tissue (HP:0009025) | 3.41021536 |
| 29 | Difficulty running (HP:0009046) | 3.32178287 |
| 30 | EMG: neuropathic changes (HP:0003445) | 3.27503963 |
| 31 | Primary atrial arrhythmia (HP:0001692) | 3.26828752 |
| 32 | Lipoatrophy (HP:0100578) | 3.26697748 |
| 33 | Syncope (HP:0001279) | 3.24540909 |
| 34 | Abnormality of the calf musculature (HP:0001430) | 3.19556058 |
| 35 | Visceral angiomatosis (HP:0100761) | 3.17392003 |
| 36 | Supraventricular arrhythmia (HP:0005115) | 3.12691897 |
| 37 | Supraventricular tachycardia (HP:0004755) | 3.08893132 |
| 38 | Areflexia of lower limbs (HP:0002522) | 3.06935236 |
| 39 | Bundle branch block (HP:0011710) | 2.99155995 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 2.98405363 |
| 41 | Hyperkalemia (HP:0002153) | 2.98077115 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.95835083 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.90794642 |
| 44 | Subaortic stenosis (HP:0001682) | 2.90794642 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.90644410 |
| 46 | Dilated cardiomyopathy (HP:0001644) | 2.90436852 |
| 47 | Stage 5 chronic kidney disease (HP:0003774) | 2.90219649 |
| 48 | Hemangiomatosis (HP:0007461) | 2.89878152 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.86884082 |
| 50 | Lymphangioma (HP:0100764) | 2.79384593 |
| 51 | Rapidly progressive (HP:0003678) | 2.78993085 |
| 52 | Calcaneovalgus deformity (HP:0001848) | 2.77321367 |
| 53 | Palpitations (HP:0001962) | 2.75803938 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.75077096 |
| 55 | Absent phalangeal crease (HP:0006109) | 2.70641437 |
| 56 | Prolonged QT interval (HP:0001657) | 2.67191192 |
| 57 | Bulbar palsy (HP:0001283) | 2.61894389 |
| 58 | Rhabdomyolysis (HP:0003201) | 2.59735681 |
| 59 | Cerebral hemorrhage (HP:0001342) | 2.58376556 |
| 60 | Esophageal varix (HP:0002040) | 2.57609880 |
| 61 | Broad metatarsal (HP:0001783) | 2.57414207 |
| 62 | Muscle fiber inclusion bodies (HP:0100299) | 2.52852817 |
| 63 | Potter facies (HP:0002009) | 2.51102617 |
| 64 | Facial shape deformation (HP:0011334) | 2.51102617 |
| 65 | Cavernous hemangioma (HP:0001048) | 2.50698892 |
| 66 | Glomerulonephritis (HP:0000099) | 2.49418421 |
| 67 | Heart block (HP:0012722) | 2.49416632 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 2.48299756 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.45722168 |
| 70 | Ventricular arrhythmia (HP:0004308) | 2.44050880 |
| 71 | Tubulointerstitial fibrosis (HP:0005576) | 2.40899631 |
| 72 | Deformed tarsal bones (HP:0008119) | 2.40784929 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.36017532 |
| 74 | Abnormal atrioventricular conduction (HP:0005150) | 2.35557852 |
| 75 | Difficulty climbing stairs (HP:0003551) | 2.35494202 |
| 76 | Atrioventricular block (HP:0001678) | 2.35432267 |
| 77 | Scapular winging (HP:0003691) | 2.30427859 |
| 78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.28376148 |
| 79 | Malignant hyperthermia (HP:0002047) | 2.28147433 |
| 80 | Abnormality of chloride homeostasis (HP:0011422) | 2.27643349 |
| 81 | Hypokalemic alkalosis (HP:0001949) | 2.26431380 |
| 82 | Foot dorsiflexor weakness (HP:0009027) | 2.26188225 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 2.24335828 |
| 84 | Myotonia (HP:0002486) | 2.24123320 |
| 85 | Gowers sign (HP:0003391) | 2.22687852 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22481825 |
| 87 | Hypoproteinemia (HP:0003075) | 2.22453745 |
| 88 | Limb-girdle muscle atrophy (HP:0003797) | 2.19945042 |
| 89 | Hyperaldosteronism (HP:0000859) | 2.18817211 |
| 90 | Abnormal finger flexion creases (HP:0006143) | 2.18265549 |
| 91 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14919155 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.11290543 |
| 93 | Muscle stiffness (HP:0003552) | 2.10409849 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09475117 |
| 95 | Tubular atrophy (HP:0000092) | 2.09438081 |
| 96 | Lower limb amyotrophy (HP:0007210) | 2.08622330 |
| 97 | Muscular dystrophy (HP:0003560) | 2.07538431 |
| 98 | Tachypnea (HP:0002789) | 2.06865767 |
| 99 | Hydroxyprolinuria (HP:0003080) | 2.03091164 |
| 100 | Abnormality of proline metabolism (HP:0010907) | 2.03091164 |
| 101 | Weak cry (HP:0001612) | 2.01610133 |
| 102 | Proximal amyotrophy (HP:0007126) | 2.01476940 |
| 103 | Nemaline bodies (HP:0003798) | 2.00788926 |
| 104 | Generalized muscle weakness (HP:0003324) | 1.99309304 |
| 105 | Hypoplastic left heart (HP:0004383) | 1.99169194 |
| 106 | Nonprogressive disorder (HP:0003680) | 1.99084307 |
| 107 | Rectal prolapse (HP:0002035) | 1.98448348 |
| 108 | Ketoacidosis (HP:0001993) | 1.96347167 |
| 109 | Ventricular fibrillation (HP:0001663) | 1.95905691 |
| 110 | Spinal rigidity (HP:0003306) | 1.95496140 |
| 111 | Aneurysm (HP:0002617) | 1.94247555 |
| 112 | Cerebral aneurysm (HP:0004944) | 1.93624640 |
| 113 | Hypoglycemic coma (HP:0001325) | 1.93405221 |
| 114 | Respiratory distress (HP:0002098) | 1.91029185 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.89042335 |
| 116 | Gout (HP:0001997) | 1.88558187 |
| 117 | Neonatal respiratory distress (HP:0002643) | 1.87882362 |
| 118 | Renal salt wasting (HP:0000127) | 1.87876447 |
| 119 | Aortic aneurysm (HP:0004942) | 1.87304546 |
| 120 | Slender build (HP:0001533) | 1.86866937 |
| 121 | Facial diplegia (HP:0001349) | 1.86272819 |
| 122 | Nephrotic syndrome (HP:0000100) | 1.85592083 |
| 123 | Neck muscle weakness (HP:0000467) | 1.84982101 |
| 124 | Abnormality of potassium homeostasis (HP:0011042) | 1.82542529 |
| 125 | Hematuria (HP:0000790) | 1.82212532 |
| 126 | Progressive muscle weakness (HP:0003323) | 1.79611680 |
| 127 | Frequent falls (HP:0002359) | 1.79188844 |
| 128 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79088650 |
| 129 | Fatigable weakness (HP:0003473) | 1.79088650 |
| 130 | Waddling gait (HP:0002515) | 1.78046370 |
| 131 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.77155608 |
| 132 | Hip contracture (HP:0003273) | 1.75541441 |
| 133 | Steppage gait (HP:0003376) | 1.74250109 |
| 134 | Abnormal EKG (HP:0003115) | 1.70495722 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.69796792 |
| 136 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.63174779 |
| 137 | Hyperuricemia (HP:0002149) | 1.58479938 |
| 138 | Increased purine levels (HP:0004368) | 1.58479938 |
| 139 | Left ventricular hypertrophy (HP:0001712) | 1.55397421 |
| 140 | Sudden cardiac death (HP:0001645) | 1.53005087 |
| 141 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.51120690 |
| 142 | Abnormality of the calcaneus (HP:0008364) | 1.49437698 |
| 143 | Palmoplantar keratoderma (HP:0000982) | 1.47892089 |
| 144 | Increased muscle lipid content (HP:0009058) | 1.47851336 |
| 145 | Oligomenorrhea (HP:0000876) | 1.47541589 |
| 146 | Toxemia of pregnancy (HP:0100603) | 1.45059578 |
| 147 | Increased intramyocellular lipid droplets (HP:0012240) | 1.44498538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.25312297 |
| 2 | TTN | 3.69275976 |
| 3 | MYLK | 3.38002794 |
| 4 | TGFBR2 | 3.17477150 |
| 5 | EPHB2 | 2.92211502 |
| 6 | OBSCN | 2.87188629 |
| 7 | WNK4 | 2.41166084 |
| 8 | LMTK2 | 2.40219748 |
| 9 | KDR | 2.39132936 |
| 10 | TRIB3 | 2.30839857 |
| 11 | PHKG2 | 2.24207223 |
| 12 | PHKG1 | 2.24207223 |
| 13 | PIK3CG | 2.12313421 |
| 14 | DMPK | 2.11172569 |
| 15 | RIPK1 | 1.97683831 |
| 16 | PAK4 | 1.84963115 |
| 17 | PDK4 | 1.80002484 |
| 18 | PDK3 | 1.80002484 |
| 19 | EPHB1 | 1.77273958 |
| 20 | PDK2 | 1.58840361 |
| 21 | PDGFRA | 1.44096925 |
| 22 | STK39 | 1.42233019 |
| 23 | FGFR4 | 1.40113156 |
| 24 | PIK3CA | 1.37676971 |
| 25 | LRRK2 | 1.34790838 |
| 26 | PKN2 | 1.34649235 |
| 27 | MAP2K3 | 1.32946687 |
| 28 | TGFBR1 | 1.31435790 |
| 29 | FER | 1.30181044 |
| 30 | MAP3K7 | 1.30172187 |
| 31 | LATS1 | 1.23617567 |
| 32 | MST4 | 1.23229110 |
| 33 | PTK6 | 1.21501595 |
| 34 | ERN1 | 1.20100874 |
| 35 | STK24 | 1.17636523 |
| 36 | MAP3K3 | 1.17289680 |
| 37 | OXSR1 | 1.12908721 |
| 38 | PRKD1 | 1.08367403 |
| 39 | NME1 | 1.01633557 |
| 40 | BCKDK | 0.97910261 |
| 41 | FGFR3 | 0.92992197 |
| 42 | ROCK1 | 0.92471074 |
| 43 | NEK9 | 0.90870550 |
| 44 | GRK1 | 0.85603929 |
| 45 | LIMK1 | 0.84167729 |
| 46 | CAMK2G | 0.83837452 |
| 47 | PRKG2 | 0.83190315 |
| 48 | INSRR | 0.82700154 |
| 49 | MAPK7 | 0.82547257 |
| 50 | FRK | 0.80686916 |
| 51 | STK10 | 0.80205520 |
| 52 | MARK1 | 0.79729808 |
| 53 | EEF2K | 0.78482267 |
| 54 | FGFR2 | 0.78183697 |
| 55 | PAK3 | 0.76679998 |
| 56 | PINK1 | 0.76604037 |
| 57 | PRPF4B | 0.73769222 |
| 58 | PRKAA2 | 0.73630298 |
| 59 | NEK1 | 0.73573798 |
| 60 | ILK | 0.72453942 |
| 61 | JAK1 | 0.71141335 |
| 62 | PDPK1 | 0.70890525 |
| 63 | TRPM7 | 0.70439061 |
| 64 | MAP2K4 | 0.69988069 |
| 65 | MAPK12 | 0.68396682 |
| 66 | MAP3K6 | 0.67428945 |
| 67 | PDGFRB | 0.67100736 |
| 68 | AKT3 | 0.65225253 |
| 69 | NLK | 0.65034882 |
| 70 | ACVR1B | 0.64145805 |
| 71 | PTK2B | 0.64107612 |
| 72 | TYK2 | 0.63520785 |
| 73 | MAP2K6 | 0.63336269 |
| 74 | MST1R | 0.63192176 |
| 75 | GRK7 | 0.62812935 |
| 76 | EPHA3 | 0.60305616 |
| 77 | MAPK4 | 0.59634968 |
| 78 | PRKCH | 0.59190238 |
| 79 | DYRK1B | 0.58867578 |
| 80 | CAMK1D | 0.57810999 |
| 81 | CSK | 0.57805919 |
| 82 | CAMK2A | 0.56148660 |
| 83 | ERBB3 | 0.55649986 |
| 84 | PRKG1 | 0.54208749 |
| 85 | STK38L | 0.53746054 |
| 86 | MAPK11 | 0.53689528 |
| 87 | TBK1 | 0.53413389 |
| 88 | GSK3A | 0.53303722 |
| 89 | PRKAA1 | 0.50705887 |
| 90 | WNK1 | 0.49599103 |
| 91 | MAP2K1 | 0.49263760 |
| 92 | SGK3 | 0.48773350 |
| 93 | MAPKAPK3 | 0.47709999 |
| 94 | SGK2 | 0.47622094 |
| 95 | RPS6KC1 | 0.47373113 |
| 96 | RPS6KL1 | 0.47373113 |
| 97 | KSR2 | 0.47356215 |
| 98 | CAMK1 | 0.44850844 |
| 99 | SIK1 | 0.44153564 |
| 100 | KIT | 0.43458088 |
| 101 | PRKCE | 0.43285977 |
| 102 | CAMK1G | 0.42755480 |
| 103 | MOS | 0.41146458 |
| 104 | MAP3K1 | 0.40653502 |
| 105 | MAP3K13 | 0.39449034 |
| 106 | PRKACA | 0.39313583 |
| 107 | PTK2 | 0.39102362 |
| 108 | EPHA2 | 0.38987350 |
| 109 | RPS6KA6 | 0.38983452 |
| 110 | MET | 0.38628028 |
| 111 | CAMK4 | 0.38304198 |
| 112 | CAMK2D | 0.37833212 |
| 113 | LATS2 | 0.36667088 |
| 114 | ROCK2 | 0.36614819 |
| 115 | DAPK2 | 0.36471470 |
| 116 | MAP2K2 | 0.35078242 |
| 117 | MARK2 | 0.34955914 |
| 118 | JAK2 | 0.33476477 |
| 119 | MAP3K2 | 0.33094753 |
| 120 | CAMK2B | 0.32768017 |
| 121 | RPS6KA2 | 0.32330914 |
| 122 | EGFR | 0.31602147 |
| 123 | CDC42BPA | 0.31339750 |
| 124 | ZAP70 | 0.30698873 |
| 125 | PDK1 | 0.30479386 |
| 126 | MAP3K10 | 0.30105658 |
| 127 | AKT2 | 0.29106403 |
| 128 | MUSK | 0.28381460 |
| 129 | PKN1 | 0.28147110 |
| 130 | PRKACB | 0.27940250 |
| 131 | ICK | 0.27042003 |
| 132 | PRKACG | 0.26519674 |
| 133 | RPS6KA3 | 0.26329344 |
| 134 | SGK223 | 0.26138627 |
| 135 | SGK494 | 0.26138627 |
| 136 | SRC | 0.25313243 |
| 137 | SGK1 | 0.24466606 |
| 138 | RPS6KA1 | 0.23761063 |
| 139 | MAP3K5 | 0.23523838 |
| 140 | BLK | 0.22309233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.61416006 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.99512071 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.89469884 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.64115496 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.52267731 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.41994203 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37245516 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29706822 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16080040 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 1.95265365 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 1.91974571 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.79032334 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66174967 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58189911 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57365991 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 1.57078573 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57007384 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55054437 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51245079 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50598607 |
| 21 | Amoebiasis_Homo sapiens_hsa05146 | 1.49691282 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.49500042 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.48110188 |
| 24 | Tight junction_Homo sapiens_hsa04530 | 1.42771149 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42036473 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37838124 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.37819129 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32549808 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31715142 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31132741 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20306391 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.12693510 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12626067 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10749017 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08579358 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02678495 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00390254 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00135810 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99844855 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97730811 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97141775 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96973270 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.95395341 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94865520 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93464953 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90418645 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90282402 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90024420 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88369081 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.87918072 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87305181 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83615326 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.82158457 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81954517 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.81171602 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78672500 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77034355 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75594645 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75035226 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74034683 |
| 61 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73781916 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71831275 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70767815 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67786243 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67578514 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67227511 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66736491 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65082605 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64004805 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63616298 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63613750 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63046416 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.62097379 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61814730 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59821107 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59398260 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.59173939 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58856934 |
| 79 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58350091 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58217532 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57576559 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57415975 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56942957 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56707127 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55776540 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55106794 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53373041 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51922692 |
| 89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51676326 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51448752 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.51319815 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50534234 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49726026 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49553846 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49463767 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.47110584 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.46726031 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46550092 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45608718 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44756136 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44507711 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42197502 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41933109 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.41006869 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.40172510 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39372049 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.39259036 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39074869 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39008899 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38593318 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37344916 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36914412 |
| 113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36684109 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.36392875 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36079200 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35621748 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.34002992 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33961997 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33383442 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32662289 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32004070 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31920758 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31607600 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31380688 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24961003 |
| 126 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21725604 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20622275 |

